Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |